analysts: su chen gina huang xuhao yang jonathan barki date: november 10 th, 2011 1

25
Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th , 2011 1

Upload: jaime-duford

Post on 20-Jan-2016

219 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki

Date: November 10th, 2011

1

Page 2: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

RCMP currently holds 500 shares of WAG, bought on 6th Oct 1999 at the price of $25

For the previous trade day , WAG closed at $ 31.72 @11/9/2011

Holding value is 16% of total portfolio value

2

Portfolio Position

Page 3: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Product Class

3

Page 4: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Walgreen Drug Retail Market Share

4

Page 5: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Margin Analysis

5

Page 6: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Dupont Analysis

6

Page 7: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Slow Store Growth

7

Page 8: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Treasury Stock Plan

8

Page 9: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Past 5 Year Stock Performance

9Source: Yahoo Finance

Page 10: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Stock Performance Comparison

10 Source: WSJ

Page 11: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Industry Structure

11 Source: IBIS World

Page 12: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Per capita disposable income

12

Per capita disposable income determines an individual's ability to purchase goods or services

Positive job growth and lower savings will lead to an annual growth rate of 1.6% over the outlook period, but the growth will be hindered by higher tax rates needed to balance the fiscal deficit.

Source: IBISWorld

Page 13: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Number of adults over 65 years old

13

Older people are more likely to require medical attention or assistance

Baby boomers have started reaching the age of 65, resulting in growth of over 3% a year

The expansion of this group will be aided by further medical innovations, superior nutrition and improved safety

Source: US Census Bureau

Page 14: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Number of people with private health insurance

14

The number of people with private health insurance has declined during the five years to 2011, in response to the poor economic environment.

The number of people with private health insurance is forecast to increase considerably during the five years to 2016, particularly in 2014, when a health insurance exchange will be initiated.

Ultimately, 32 million previously uninsured individuals are forecast to gain coverage by 2019.

Source: US Census Bureau

Page 15: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Federal funding for Medicare and Medicaid

15

Medicaid is geared towards people with low incomes and Medicare covers almost everyone 65 or older

The Congressional Budget Office projects that Federal funding for Medicare and Medicaid will rise at 6.70% per year to surpass a trillion dollars by 2016. This growth

Funding for Medicare rises at a high but largely stable rate. This is because changes are driven by demographic shifts which occur predictably and slowly over time. Meanwhile, Medicaid expenditures fluctuate in accordance with the business cycle making it more volatile.

Source: Office of Management and Budget

Page 16: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

When the patent of a brand name medication expires, a generic version of the drug can be produced and sold.

Generic drugs are as safe and effective as the brand name equivalent, with exactly the same ingredients, but are much cheaper

In general, generic drugs generate lower total sales dollars per prescription, but higher gross profit margins , compared with patent-protected brand name drugs.

Generic drugs are more profitable for wholesalers because of the enhanced bargaining position with generic manufacturers

16

Generic drugs VS brand name drugs

Page 17: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

17

Big Three Wholesalers, Revenues and Gross Profits, Brand vs. Generic Drugs

Source: Pembroke Consulting estimates

 Generic drugs represent about 9% of revenues but 56% of gross profits

Page 18: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Walgreens to benefit from expiring patents

Patents to expire in 201123% of Walgreens’ prescription drugs sales Patents to expire in 2012

42% of Walgreens’ prescription drugs sales

18

Patent Expiring

Company

2010 U.S. sales

Lipitor Pfizer $5,329M

Zyprexa Eli Lily $2,496M

Levaquin Johnson&Johnson

$1,312M

Concerta Johnson&Johnson

$929M

Protonix Pfizer $690M

Patent Expiring

Company 2010 U.S. sales

Plavix Sanofi $6,154M

Seroquel Astrazeneca

$3,747M

Singulair Merck $3,224M

Actos Takeda $3,351M

Enbrel Amgen $3,304

Source: IBIS World

Page 19: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Biggest drugstore chain VS Top three PBMs

Walgreens failed to agree on new contract terms with Express Script, one of the three largest Pharmacy Benefit Managers(PBM)

The break-up with Express Script will cost Walgreens about $5 billion in annual sales, or about seven percent of its business.

19

Page 20: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

 Pharmacy Benefit Manager (PBM) is a third party administrator of prescription drug programs, primarily responsible for processing and paying prescription drug claims. 

PBMs like Express Scripts and Medco are patients' first point of contact with the pharmaceutical supply chain. These PBMs are using their massive scale to wield stronger bargaining power over retailers, and are encouraging consumers to switch to their own low-cost mail-order facilities instead of retail drugstores

As a result, retail drugstores like Walgreens are facing unprecedented reimbursement and competitive pressure.

Pharmacy Benefit Manager(PBM)

20

Page 21: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Many organizations in the healthcare industry, including pharmacy benefit managers, have consolidated in recent years to create larger healthcare enterprises with greater market power, which has resulted in greater pricing pressures to WAG

Two of the three largest pharmacy benefit managers, Medco Health Solutions, Inc. and Express Scripts, Inc., announced an agreement to merge in July 2011, completion of which is subject to regulatory and other conditions.

If this consolidation trend continues, it may lead to further pressure on the prices for our products and services and adversely affect our business.

21

Consolidation in the healthcare industry

Page 22: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Closest CompetitorsCVS: The Pharmacy Services segment provides pharmacy benefit management (PBM) services, mail order services specialty pharmacy services, plan design and administration and claims processing.The Retail Pharmacy segment sells prescription drugs and general merchandise. General merchandise include over-the-counter drugs, beauty products, cosmetics, film and photo finishing services, greeting cards, and convenience foods.

Rite Aid:Rite Aid sells prescription drugs and front end products. Front end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, beverages, convenience foods, greeting cards, seasonal merchandise, photo processing, and other everyday products.

Page 23: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

ConcernsLIFO Inventory ReportingEffects Costs of Goods Sold Net Income and EBIT

Operating Property Leases as oppose to Capital Property LeasesOverstates Operating Expenditure Impacts Net Income and EBITUnderstates Debt Impacts Enterprise ValueMust be taken into consideration with Multiples

Cutting ties with Express Scripts$5.3 billion sales lost, 7% overall salesEffect earnings by 50 cents

Page 24: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Final Price

24

$34.31

DCF $33.24

Multiple 1$35.53

Multiple 2$41.66

80%

10% 10%

Page 25: Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th, 2011 1

Our Recommendation

25

Stock price as of (11/9/2011):

$31.72

HOLD